Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA to make safety reviews public

June 16, 2010
Research and Development, Sales and Marketing FDA, drug safety

The US medicines regulator is to make safety reviews of recently approved prescription medicines more readily available to the public. …

News

Former FDA and MHRA regulators join Parexel Consulting

June 16, 2010
Research and Development CRO, Parexel, appointment, research and development

Parexel Consulting has appointed former regulators Toby Silverman, M.D. and Keith Watson, Ph.D. as principal consultants. The company is a …

News

Novo agrees price cut deal with Greece

June 16, 2010
Sales and Marketing Greece, Novo Nordisk, insulin, pricing

Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …

News

GSK’s Votrient approved in Europe

June 16, 2010
Sales and Marketing GlaxoSmithKline, Kidney cancer, Votrient

The European Commission has granted a conditional marketing authorisation for a GlaxoSmithKline drug that treats the most common form of …

News

R&D: a new world order

June 16, 2010
Manufacturing and Production, Research and Development industry, job cuts, research, research and development

Big pharma is today demolishing the in-house drug discovery and research structures built up over the last decade, and is …

Feature

Patrick Walker appointed to PPRS resolution panel

June 16, 2010
Sales and Marketing DH, UK, appointment, sales and marketing

The Department of Health has appointed Patrick Walker to chair the Dispute Resolution Panel for UK pricing system the Pharmaceutical …

Appointment

Novavax makes manufacturing promotions

June 16, 2010
Manufacturing and Production, Research and Development Novavax, appointment, manufacturing and production, research and development

US biotech company Novavax has made a brace of manufacturing management promotions. It has appointed John Madsen as head of …

Appointment

Nexavar fails in lung cancer trial

June 15, 2010
Research and Development Bayer, NSCLC, Nexavar, Onyx

Bayer and Onyx Pharmaceutical’s oncology drug Nexavar has failed to meet its primary endpoint in a phase III study for …

News

Pfizer forms rare diseases unit

June 15, 2010
Research and Development Orphan, Pfizer

Pfizer is seeking to boost its coverage of research into orphan conditions with the creation of a new unit focused …

News
Ben_Fisher

Ben Fisher joins OgilvyHealthPR

June 15, 2010
Medical Communications Ogilvy, appointment, medical communications

OgilvyHealthPR has appointed Ben Fisher as associate director. He joins the agency from Porter Novelli and has ten years experience …

Appointment

Management appointments at Novasep

June 15, 2010
Manufacturing and Production Novasep, appointment, manufacturing and production

Pharma manufacturing company Novasep has appointed Stephen Stefano to head up its US business and Patrick Glasser to lead its …

Appointment

Patheon back in the black, secures major Merck contract

June 15, 2010
Manufacturing and Production Patheon

Contract services company Patheon swung back into profit in the second quarter of the year, helped by a weak dollar, …

News
Victoza pack

Victoza wins partial NICE recommendation

June 15, 2010
Sales and Marketing NICE, Victoza, diabetes

Novo Nordisk has been given a limited approval for its new type II diabetes treatment in draft guidance issued by …

News

Early halt for successful apixaban trial

June 14, 2010
Research and Development apixaban, atrial fibrilation

Pfizer and Bristol-Myers Squibb’s atrial fibrillation treatment apixaban has performed so well in a phase III trial that it has …

News
Blog footer

Digital Pharma: Janssen gets animated about ADHD

June 14, 2010
Medical Communications, Sales and Marketing ADHD, Janssen, disease awareness campaigns

Janssen-Cilag has launched a new UK campaign to raise awareness of ADHD among teenagers, their parents and teachers. The campaign’s …

News

Boehringer denies Micardis cancer link

June 14, 2010
Sales and Marketing ACE-inhibitors, ARB, Boehringer, Micardis, drug safety

Boehringer Ingelheim has given a robust rebuttal to a Lancet report implicating its hypertension drug Micardis (telmisartan) in scares about …

News

Pharma pools trial data for brain disorder research

June 14, 2010
Research and Development Alzheimer's, Huntington's, Parkinson's, clinical trials, partnerships

Leading pharma companies have come together for a major new research collaboration aimed at improving clinical trials for Alzheimer’s, Parkinson’s, …

News

Brecon appoints Nycomed’s Dr Herbert Pomper

June 14, 2010
Manufacturing and Production Brecon, appointment, manufacturing and production

Packaging and clinical supply services company Brecon Pharmaceuticals has appointed Dr Herbert Pomper to the newly created role of associate …

Appointment

Doctors.net.uk appoints Gareth Thomas

June 14, 2010
Medical Communications, Sales and Marketing appointment, doctors.net, medical communications, sales and marketing

Gareth Thomas has joined UK online medical professional network Doctors.net.uk as international development director.

Appointment

Implementing value-based pricing in the UK

June 14, 2010
Sales and Marketing hta, pricing, value

The UK has a strong history of innovation in medicines and it is vital to the economy that this continues …

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026